Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
3.030
-0.120 (-3.81%)
At close: Aug 20, 2026, 4:00 PM EDT
3.030
0.00 (0.00%)
After-hours: Aug 20, 2026, 4:10 PM EDT

Apyx Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Apyx Medical stock has a consensus rating of "Strong Buy" and an average price target of $6.60. The average 1-year stock price forecast is 117.82% higher than the current stock price, while the lowest is $6.00 (+98.02%) and the highest is $8.00 (+164.03%).

Price Target: $6.60 (+117.82%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$6.00$6.60$6.00$8.00
Change+98.02%+117.82%+98.02%+164.03%

Analyst Ratings

The average analyst rating for Apyx Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jul '26Aug '26
Strong Buy344344
Buy111111
Hold100000
Sell000000
Strong Sell000000
Total555455

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Buy
Reiterates
$6
BuyReiterates$6+98.02%Aug 7, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$7
BuyReiterates$7+131.02%Aug 7, 2026
Craig-Hallum
Craig-Hallum
Buy
Reiterates
$6
BuyReiterates$6+98.02%May 8, 2026
Roth MKM
Roth MKM
Buy
Reiterates
$6
BuyReiterates$6+98.02%Apr 14, 2026

Financial Forecast

Revenue This Year
59.45M
from 52.84M
Increased by 12.50%
Revenue Next Year
66.04M
from 59.45M
Increased by 11.08%
EPS This Year
-0.29
from -0.27
EPS Next Year
-0.25
from -0.29
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
48.52M44.51M52.35M48.10M52.84M59.45M
Revenue Growth
75.08%-8.26%17.61%-8.11%9.86%12.50%
Gross Profit
33.60M29.13M33.76M29.36M33.04M37.17M
Gross Margin
69.26%65.45%64.49%61.04%62.53%62.53%
Operating Income
-14.45M-23.31M-19.95M-18.85M-6.45M-6.20M
Net Income
-15.17M-23.18M-18.71M-23.46M-11.21M-10.76M
EPS
-----0.27-0.29
Free Cash Flow
-5.33M-5.54M-1.90M-11.58M-7.11M-10.20M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High59.6M
Avg59.4M
Low59.3M

Revenue Growth

Revenue Growth202620272028
High
12.7%
Avg
12.5%
Low
12.2%

EPS Forecast

EPS202620272028
High-0.26
Avg-0.29
Low-0.31

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-